Insights On Outsourced Drug Development
-
Inside Bioprocessing: Continuous Perfusion
11/4/2025
Learn about the essential elements of upstream workflows, media optimization strategies, and liquid handling logistics required to implement continuous perfusion successfully.
-
Aggregate Analysis Of Tirzepatide
12/11/2025
A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.
-
Overcoming The Solubility Challenges Of Antibody-Drug Conjugates
6/3/2024
Discover a chito-oligosaccharide that significantly improves the solubility of antibody-drug conjugates (ADCs) when included in the linker-payload construct.
-
Assessment Of Compound Toxicity Effects With High-Content Imaging
3/17/2025
3D cellular models and bioprinting enhance drug safety predictions and offer precise spatial control. Explore an automated method for generating liver models to improve reproducibility and reliability in toxicity testing.
-
Unlock Efficiency: Leverage The Right Tools To Build Process Knowledge
2/3/2025
The biopharma industry must shift from data collection to process knowledge, leveraging digital tools to optimize drug development, enhance quality, and streamline tech transfer through digital maturity.
-
Non Animal Origin Squalene For High-Risk Applications
7/21/2025
Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.
-
Exosome Production From hMSC Using A Fixed-Bed Bioreactor
11/3/2025
Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.
-
Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery
6/3/2025
Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.
-
Efficacy Screening Of Antibody-Drug-Conjugates By Surface Plasmon Resonance
6/3/2024
Rapid screening of ADC affinity using surface plasmon resonance provides preliminary efficacy data in comparing antigen binding affinity with selected linkers and payloads to the non-conjugated antibody.
-
Understand Fluorescence And How It Enhances Scientific Exploration
9/24/2024
Deepen your understanding of fluorescence for research, and gain valuable insight into how to select appropriate fluorophores and fluorescent proteins for your experiments.